SUBSCRIBE
SUBSCRIBE
News   Business

Cephalon, Inc. Ending Provigil Promotion Deal with Takeda Pharmaceutical Co. Ltd.

September 5, 2008 | 
1 min read

Cephalon Inc. has provided written notice to Takeda Pharmaceuticals North America Inc. that as of Nov. 1 Cephalon is ending its co-promotion agreement covering its sleep disorder drug Provigil.

Alliances
MORE ON THIS TOPIC
Signage at Pfizer's world headquarters in New York City
Business
Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help
October 8, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Kaléo to Lay Off 58 Employees, Stryker Cuts Continue
October 7, 2024
 · 
161 min read
 · 
BioSpace Editorial Staff
Facade of AstraZeneca's office in Shanghai, China
Cardiovascular disease
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
October 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Young Woman Standing In Front Of Exit Door. Full Length, Vector, Illustration, Flat Design, Character.
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
October 4, 2024
 · 
1 min read
 · 
Angela Gabriel